Author

Hamad Ali

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Prevalence and steatosis severity of MASLD in patients with type 2 diabetes mellitus in Kuwait

Background Metabolic dysfunction–associated steatotic liver disease (MASLD) is a common comorbidity in individuals with type 2 diabetes mellitus (T2DM). Given the high prevalence of T2DM in Kuwait and limited regional data on hepatic steatosis, this study aimed to assess the prevalence and severity of liver steatosis a...

M. Altarrah, Rashed Alhammad, Saoud Ahmad et al. · Frontiers in Endocrinology · 0 citations

Oct 2026

Integrated expression profiling and structure-based drug discovery identify EGFR as a druggable target and Tripterygium wilfordii phytochemicals as potential therapeutics for autosomal dominant polycystic kidney disease.

Autosomal dominant polycystic kidney disease (ADPKD) is a progressive genetic disorder characterized by renal cyst formation and eventual kidney failure, with limited effective therapeutic options. In this study, we employed an integrated computational framework combining microarray-based gene expression profiling, net...

I. U. Haq, Israr Hussain, A. Mohammad et al. · Computational biology and ch... · 0 citations

Open access Sep 2026

Associations of Elevated Lipoprotein(a) with C-Reactive Protein and Type 2 Diabetes in a Multiethnic Population

Findings support the emerging concept that Lp(a) may function as a molecular-inflammatory mediator potentially contributing to residual cardiovascular risk and highlight the importance of incorporating Lp(a) assessment into cardiometabolic risk stratification, particularly in high-risk populations.

Mohammad G. Qaddoumi, A. Albatineh, I. Alkhairi et al. · Biomedicines · 0 citations